SEC Form 4/A · accession 0001596771-15-000010
Diplomat Pharmacy, Inc. · DPLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jeffrey M Rowe
Officer — EVP of Operations · Director
Period of report
Oct 9, 2014
Accepted (ET)
Jan 15, 2015 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 9, 2014 | S | 270,833 | $13.00 | D | 1,600,284 | D | |
| Common StockF1 | Oct 9, 2014 | S | 270,833 | $13.00 | D | 281,667 | I | Rowe Family Trusts |
| Common Stock | holding | — | — | — | 59,500 | I | Irrevocable Exempt Trust for Daughter | |
| Common Stock | holding | — | — | — | 59,500 | I | Irrevocable Exempt Trust for Son | |
| Common Stock | holding | — | — | — | 59,500 | I | Irrevocable Exempt Trust for Son | |
| Common Stock | holding | — | — | — | 59,500 | I | Irrevocable Exempt Trust for Daughter | |
| Common Stock | holding | — | — | — | 59,500 | I | Irrevocable Exempt Trust for Son | |
| Common Stock | holding | — | — | — | 127,500 | I | Rowe Charitable Remainder Unitrust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold as part of the initial public offering of the Issuer's common stock. This amendment reflects the additional shares sold in the initial public offering pursuant to the underwriters' exercise of an option to purchase such shares in connection with such offering; the additional sale of shares was inadvertently omitted from the initial filing.